143 related articles for article (PubMed ID: 20799046)
21. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
22. Neuroradiological viewpoint on the diagnostics of space-occupying brain lesions.
Faehndrich J; Weidauer S; Pilatus U; Oszvald A; Zanella FE; Hattingen E
Clin Neuroradiol; 2011 Sep; 21(3):123-39. PubMed ID: 21538040
[TBL] [Abstract][Full Text] [Related]
23. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
[TBL] [Abstract][Full Text] [Related]
25. [Possibilities of the use of MR tomography-based cerebral blood volume maps in the diagnosis of brain tumors].
Hackländer T; Hofer M; Reichenbach J; Bettag JM; Kiwit JC; Herzog H; Mödder U
Rofo; 1995 Dec; 163(6):484-9. PubMed ID: 8547618
[TBL] [Abstract][Full Text] [Related]
26. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases.
Chawla S; Zhang Y; Wang S; Chaudhary S; Chou C; O'Rourke DM; Vossough A; Melhem ER; Poptani H
J Comput Assist Tomogr; 2010; 34(6):836-41. PubMed ID: 21084897
[TBL] [Abstract][Full Text] [Related]
27. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility.
Aronen HJ; Glass J; Pardo FS; Belliveau JW; Gruber ML; Buchbinder BR; Gazit IE; Linggood RM; Fischman AJ; Rosen BR
Acta Radiol; 1995 Sep; 36(5):520-8. PubMed ID: 7640098
[TBL] [Abstract][Full Text] [Related]
28. Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases.
Kremer S; Grand S; Berger F; Hoffmann D; Pasquier B; Rémy C; Benabid AL; Bas JF
Neuroradiology; 2003 Jan; 45(1):44-9. PubMed ID: 12525954
[TBL] [Abstract][Full Text] [Related]
29. Perfusion magnetic resonance imaging for parametric response maps in tumors: is it really that easy?
Heiland S; Wick W; Bendszus M
J Clin Oncol; 2010 Oct; 28(29):e591; author reply e592. PubMed ID: 20837945
[No Abstract] [Full Text] [Related]
30. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas.
Di Costanzo A; Pollice S; Trojsi F; Giannatempo GM; Popolizio T; Canalis L; Armillotta M; Maggialetti A; Carriero A; Tedeschi G; Scarabino T
Radiol Med; 2008 Feb; 113(1):134-43. PubMed ID: 18338133
[TBL] [Abstract][Full Text] [Related]
31. Perfusion-weighted imaging of peritumoral edema can aid in the differential diagnosis of glioblastoma mulltiforme versus brain metastasis.
Halshtok Neiman O; Sadetzki S; Chetrit A; Raskin S; Yaniv G; Hoffmann C
Isr Med Assoc J; 2013 Feb; 15(2):103-5. PubMed ID: 23516772
[TBL] [Abstract][Full Text] [Related]
32. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
[TBL] [Abstract][Full Text] [Related]
33. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
34. Preoperative Grading of Glioma Using Dynamic Susceptibility Contrast MRI: Relative Cerebral Blood Volume Analysis of Intra-tumoural and Peri-tumoural Tissue.
Soliman RK; Gamal SA; Essa AA; Othman MH
Clin Neurol Neurosurg; 2018 Apr; 167():86-92. PubMed ID: 29471287
[TBL] [Abstract][Full Text] [Related]
35. Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.
Jain R; Narang J; Griffith B; Bagher-Ebadian H; Scarpace L; Mikkelsen T; Littenberg B; Schultz LR
Acad Radiol; 2013 Apr; 20(4):478-85. PubMed ID: 23498990
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
[TBL] [Abstract][Full Text] [Related]
37. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors.
Weber MA; Zoubaa S; Schlieter M; Jüttler E; Huttner HB; Geletneky K; Ittrich C; Lichy MP; Kroll A; Debus J; Giesel FL; Hartmann M; Essig M
Neurology; 2006 Jun; 66(12):1899-906. PubMed ID: 16801657
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of metastases from high-grade gliomas using short echo time 1H spectroscopy.
Opstad KS; Murphy MM; Wilkins PR; Bell BA; Griffiths JR; Howe FA
J Magn Reson Imaging; 2004 Aug; 20(2):187-92. PubMed ID: 15269942
[TBL] [Abstract][Full Text] [Related]
40. MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens.
Tovi M; Hartman M; Lilja A; Ericsson A
Acta Radiol; 1994 Sep; 35(5):495-505. PubMed ID: 8086262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]